Clinical Trials Directory

Trials / Completed

CompletedNCT03935802

Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy

Status
Completed
Phase
Study type
Observational
Enrollment
161 (actual)
Sponsor
University of Jena · Academic / Other
Sex
Female
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to investigate the systemic effect of radiotherapy on patients with primary non-metastatic breast cancer using CETC and to analyze possible changes in CETC quantity under adjuvant radiotherapy.

Detailed description

In cooperation with the Women's Hospital of the Friedrich Schiller University in Jena, a total of 161 patients with clinically proven, primarily non-metastatic breast cancer were sampled and examined before and after radiotherapy over a period from 09/2002 to 09/2012. The MAINTRAC method was used to quantitatively determine the amount of CETC in the blood and to observe its peritherapeutic course.

Conditions

Interventions

TypeNameDescription
RADIATIONradiation

Timeline

Start date
2002-09-01
Primary completion
2012-09-01
Completion
2018-09-01
First posted
2019-05-02
Last updated
2019-05-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03935802. Inclusion in this directory is not an endorsement.

Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer (NCT03935802) · Clinical Trials Directory